Cogent Biosciences Inc. (COGT)
NASDAQ: COGT
· Real-Time Price · USD
11.88
0.17 (1.45%)
At close: Aug 15, 2025, 3:59 PM
11.89
0.08%
After-hours: Aug 15, 2025, 05:29 PM EDT
Cogent Biosciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 4.29M | 4.29M | 4.29M | 5.59M | 5.59M | 5.59M | 5.59M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | 312K | 840K |
Cost of Revenue | 3.39M | 3.31M | 3.24M | 4.04M | 3.79M | 3.93M | 3.59M | 3.73M | 6.59M | 5.47M | 4.81M | 3.94M | 282K | 199K | 147K | 6.19M | 11.14M | 16.26M |
Gross Profit | -1.25M | -1.17M | -1.1M | 1.55M | 1.79M | 1.66M | 2M | -3.73M | -6.59M | -5.47M | -4.81M | -3.94M | -282K | -199K | -147K | -6.19M | -10.83M | -15.42M |
Operating Income | -299.66M | -288.47M | -275.94M | -260.43M | -244.6M | -227.3M | -208.13M | -193.65M | -170.89M | -159.66M | -147.84M | -129.73M | -112.73M | -94.17M | -75.55M | -61.37M | -98.75M | -88.86M |
Interest Income | 13.96M | 16.98M | 18.09M | 18.1M | 17.52M | 14.87M | 13.08M | 11.32M | 8.62M | 6.15M | 3.99M | 1.99M | 601K | 449K | 467K | 431K | 339K | 222K |
Pretax Income | -284.08M | -269.5M | -255.86M | -242.3M | -227.04M | -212.17M | -192.41M | -177.66M | -157.34M | -148.19M | -140.24M | -125.53M | -109.56M | -91.18M | -72.27M | -58.7M | -89.6M | -80.44M |
Net Income | -284.08M | -269.5M | -255.86M | -242.3M | -227.04M | -212.17M | -187.76M | -168.89M | -146.81M | -137.66M | -133.57M | -122.99M | -108.77M | -90.39M | -72.27M | -58.7M | -89.6M | -80.44M |
Selling & General & Admin | 48.77M | 45.49M | 43.28M | 41.1M | 38.75M | 36.88M | 34.38M | 31.87M | 29.3M | 27.46M | 26.21M | 24.34M | 22.47M | 21M | 19.64M | 19.86M | 20.44M | 18.34M |
Research & Development | 249.73M | 242.98M | 232.66M | 219.33M | 205.84M | 190.42M | 173.75M | 161.78M | 141.59M | 132.19M | 121.63M | 105.4M | 90.26M | 73.17M | 55.91M | 41.51M | 78.62M | 71.36M |
Other Expenses | n/a | n/a | -1K | -8K | -8K | 260K | 2.64M | 4.67M | 4.93M | 4.66M | 2.28M | 259K | n/a | n/a | n/a | 15K | -255K | -248K |
Operating Expenses | 298.51M | 288.47M | 275.94M | 260.43M | 244.6M | 227.3M | 208.13M | 193.65M | 170.89M | 159.66M | 147.84M | 129.73M | 112.73M | 94.17M | 75.55M | 61.37M | 99.06M | 89.7M |
Interest Expense | 314K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 299.66M | 288.47M | 275.94M | 260.43M | 244.6M | 227.3M | 208.13M | 193.65M | 170.89M | 159.66M | 147.84M | 129.73M | 112.73M | 94.17M | 75.55M | 61.37M | 99.06M | 89.7M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -4.65M | -8.78M | -10.54M | -10.54M | -6.67M | -2.54M | -899K | -1.02M | -235K | -353K | -238K | -121K |
Shares Outstanding (Basic) | 114.47M | 113.31M | 110.46M | 110.17M | 99.24M | 94.8M | 86.73M | 86.17M | 74.75M | 70.73M | 70.49M | 69.58M | 49.39M | 45.11M | 43.81M | 39.85M | 38.44M | 34.88M |
Shares Outstanding (Diluted) | 114.47M | 113.31M | 110.46M | 110.17M | 99.24M | 94.8M | 86.73M | 86.17M | 74.75M | 70.73M | 70.49M | 69.58M | 49.39M | 45.11M | 43.81M | 39.85M | 38.44M | 34.88M |
EPS (Basic) | -2.41 | -2.36 | -2.46 | -2.48 | -2.48 | -2.48 | -2.34 | -2.21 | -2.05 | -2.17 | -2.35 | -2.42 | -2.42 | -2.14 | -1.82 | -2.33 | -6.92 | -7.44 |
EPS (Diluted) | -2.41 | -2.36 | -2.46 | -2.48 | -2.48 | -2.48 | -2.34 | -2.21 | -2.05 | -2.17 | -2.35 | -2.42 | -2.42 | -2.14 | -1.82 | -2.33 | -6.92 | -7.44 |
EBITDA | -286.94M | -278.19M | -266.2M | -257.06M | -241.74M | -224.96M | -205.86M | -191.56M | -163.91M | -153.14M | -141.78M | -124.03M | -112.45M | -93.97M | -75.4M | -61.27M | -51.67M | -41.51M |
EBIT | -291.49M | -282.66M | -270.13M | -260.43M | -244.6M | -227.3M | -208.13M | -193.65M | -170.89M | -159.66M | -147.84M | -129.73M | -112.73M | -94.17M | -75.55M | -61.37M | -91.53M | -81.64M |
Depreciation & Amortization | 4.55M | 4.47M | 4.4M | 4.04M | 3.79M | 3.93M | 3.59M | 3.73M | 6.59M | 5.47M | 4.81M | 3.94M | 282K | 199K | 147K | 96K | 170K | 442K |